DBeQ |
DBEQ |
177355-84-9 |
SCH 58261 |
SCH58261 |
160098-96-4 |
L-OrnithinaMide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]Methyl]phenyl]- |
马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 |
159857-81-5 |
PP1 |
蛋白磷酸酯酶-1(抗原) |
172889-26-8 |
PP2 |
PP2 |
172889-27-9 |
YC-1 |
利非西呱 |
170632-47-0 |
COMPOUND 401 |
COMPOUND 401 |
168425-64-7 |
MAZ51 |
CS-2885 |
163655-37-6 |
cangrelor tetrasodium |
坎格雷洛四钠盐 |
163706-36-3 |
SB 202190 |
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-30-7 |
Marimastat |
马立马司他 |
154039-60-8 |
10-Propargyl-10-deazaaminopterin |
10-炔丙基-10-去氮杂氨基蝶呤 |
146464-95-1 |
RESIQUIMOD |
雷西莫特 |
144875-48-9 |
Febuxostat |
非布索坦 |
144060-53-7 |
3-AP |
[(3-氨基吡啶-2-基)亚甲基氨基]硫脲 |
143621-35-6 |
ZM 241385 |
ZM 241385 |
139180-30-6 |
Y27632 (hydrochloride) |
Y27632 (HYDROCHLORIDE) |
129830-38-2 |
CP21R7(CP21) |
GSK-3Β抑制剂(CP21R7) |
125314-13-8 |
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)- |
3-去氮腺嘌呤A |
120964-45-6 |
dolasetron |
多拉司琼 |
115956-12-2 |